Federal Push, Florida’s Gamble & Debt Moves 🎰💼

This midweek hustle features top Dems pushing the DEA and cannabis giants placing big bets on market growth.

You're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.

Good morning folks! Nicolás Rodríguez and Patricio Liddle here. We're in the thick of it—Florida’s $100 million bet on adult-use cannabis is showing mixed results, while TerrAscend locks in a $26 million loan to slash debt in Michigan. Plus, top Democrats are urging the DEA to accelerate cannabis rescheduling. Stay sharp, stay tuned.

Florida's cannabis market is at a crossroads despite a $100 million push for adult-use legalization. While companies like Trulieve (OTC: TCNNF) and Curaleaf (OTC: CURLF) have heavily invested—contributing millions to the Smart & Safe Florida campaign—recent figures show mixed signals.

According to Beacon Securities, per-dispensary sales dropped in Q3 2024, with flower sales falling 1% and oil-based products slipping 5%. Despite challenges, Trulieve maintained its market lead, but with dispensary saturation, it's fair to question whether the current market fundamentals can sustain the anticipated boom.

With total cannabis sales in Florida projected to grow at a 12% compound annual growth rate through 2028, reaching $4.5 billion, the potential remains massive. Will these heavy investments pay off as expected? Stay tuned. 

PRESENTED BY CANNABIS CAPITAL CONFERENCE

DEA Dragging Feet, Harris Calls For Change, Industry Holds Breath

Top Democrats in the House are urging the DEA to expedite cannabis rescheduling following a Biden administration review. Representatives Jerrold Nadler (D-NY) and Frank Pallone (D-NJ) argue that cannabis has less potential for abuse and accepted medical use, pushing for reclassification to Schedule III and even considering full descheduling—a possibility we discussed in yesterday's newsletter after VP Kamala Harris stated that “we need to legalize.”

As momentum builds for federal reform, its urgency becomes clear in light of California's new hemp restrictions, which underscore the need for a unified regulatory framework across the nation. These rules, limiting hemp product sales, have sparked debates, showing how fragmented state regulations continue to challenge both the cannabis and hemp industries.

TerrAscend Corp. (OTC: TSNDF) locked in the final $26 million loan of its $140 million, targeting high-interest debt in Michigan. With a 12.75% interest rate and no prepayment penalties, the deal strengthens its balance sheet and leaves no major debt maturing until 2027—setting the stage for future growth. Other cannabis companies face key debt maturities before year-end, including Jushi (OTC: JUSHF) with $58 million due in December 2024 (21% of its total debt), and Curaleaf with $475 million maturing in December 2024 (49% of its total debt).

Ispire Technology’s (NASDAQ: ISPR) I-80 vapor device filling machine is breaking records, hitting full throttle with the ability to fill and seal 4,000 vapor devices per hour—double the speed of current automated systems and 10x more efficient than manual methods. Ispire will unveil the I-80, designed to save cannabis operators $1,000 per every 10,000 units produced, at the upcoming Benzinga Cannabis Capital Conference in Chicago on October 8-9. 

Stories In The Spotlight:

Our Writers Today

Nicolás holds a B.A. in International Relations, an M.A. in International Affairs, and an M.Phil in Public Policy. He is a doctoral student in Public and Urban Policy at The New School in New York City. After working for the United Nations in 2014, Nico pivoted his research to studying the relationship between the cannabis industry and economic development.

Patricio is a development economist with extensive experience in IT, finance, and banking. He writes about the economic and social opportunities obscured by over fifty years of drug prohibition. Beyond his professional expertise, Patricio is a committed advocate for social change, passionately working to promote harm reduction and reform drug policies.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.